Cover Image
市場調查報告書

中國的動物用疫苗產業報告

China Animal Vaccine Industry Report, 2016-2020

出版商 ResearchInChina 商品編碼 244386
出版日期 內容資訊 英文 156 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的動物用疫苗產業報告 China Animal Vaccine Industry Report, 2016-2020
出版日期: 2016年06月03日 內容資訊: 英文 156 Pages
簡介

中國的動物用疫苗市場,2014年達到約140億人民幣的市場規模,2004年∼2014年的年複合成長率達成了25.9%的高成長。預計今後需求也將持續穩定成長,2015年達約169億人民幣,維持約20.7%的成長率。

本報告提供中國的動物用疫苗產業調查分析,產業現狀,發展環境,市場區隔驗證,主要企業簡介等相關的系統性資訊。

第1章 動物用疫苗概要

  • 定義
  • 分類
  • 產業鏈

第2章 動物用疫苗產業現狀

  • 全球市場
    • 市場規模
    • 市場結構
    • 競爭情形
  • 中國市場
    • 市場規模
    • 市場結構
    • 進出口
    • 收益
    • 進入障礙
    • 競爭情形
    • 趨勢

第3章 中國的動物用疫苗產業的發展環境

  • 政策環境
    • 主要政策
    • 強制疫苗接種的競標制度
  • 社會環境
    • 畜產的穩定成長
    • 大規模畜產趨勢
    • 動物傳染病屢次發生

第4章 中國的動物用疫苗產業的市場區隔

  • 政府的強制疫苗
  • 市場導向型的疫苗
  • 寵物用疫苗

第5章 主要企業

  • CAHIC
  • Jinyu Group
  • Tecon
  • Tech-bank
  • Shenghua Biok
  • Ringpu Bio-technology
  • Wens Dahuanong
  • Hile Bio
  • Pulike
  • Chopper
  • 其他

第6章 摘要與預測

  • 摘要
  • 發展預測

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ZYM077

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen slower growth due to quality safety, high maturity and other factors, while the animal vaccine markets in emerging countries including China have developed rapidly.

The Chinese animal vaccine market size grew from RMB1.4 billion in 2004 to RMB14.0 billion in 2014 at a high rate of 25.9%, and is expected to hit around RMB16.9 billion in 2015, a year-on-year increase of 20.7%.

In China, animal vaccines fall into two categories: 1. Epidemic disease vaccines subject to national compulsory immunization programme (compulsory immunization vaccines include highly pathogenic avian influenza vaccine, foot-and-mouth disease vaccine, highly pathogenic PRRS vaccine, swine fever vaccine, and PPR vaccine in Xinjiang and Tibet); 2. Epidemic disease vaccines beyond national compulsory immunization programme (non-compulsory immunization vaccines). As the problems like low price and low quality caused by the system of purchasing by invitation to bid have greatly impacted the development of livestock and poultry breeding in China, the government has been piloting reform of the tendering system in multiple regions, planning to advance the marketization of vaccines through direct subsidies to farmers.

Large breeding companies, out of overall consideration based on economic benefits, are increasingly inclined to buy high-quality market-oriented vaccines which are 5-15 times as expensive as vaccines purchased under policy. Hence, the Chinese animal vaccine market size is expected to grow significantly in the future, reaching RMB41.2 billion in 2020.

Despite a large number of animal vaccine companies (about 100) in China, the industry is less concentrated. In 2015, China Animal Husbandry Industry Co., Ltd. (CAHIC) held the largest share (7.4%) of the Chinese animal vaccine market in 2015, followed by Jinyu Bio-technology (7.2%), Qingdao Yebio Biological Engineering (5.0%), Xinjiang Tecon Animal Husbandry Bio-Technology (4.6%), Pulike Biological Engineering (2.8%), and Tianjin Ringpu Bio-technology (2.8%).

Although the Chinese animal vaccine market is primarily controlled by domestic companies with a share of 90% or so, the high-end vaccine market, such as pet vaccines, is occupied by foreign brands including Zoetis (formerly Pfizer's animal health division), Fort Dodge, Intervet, Merial, and BoehringerIngelheim. These foreign players not only directly sell vaccines in China but also have been increasing their investment in the country.

In 2014, the animal vaccine manufacturing base, with total investment of EUR55.5 million and jointly founded by BoehringerIngelheim and Taizhou China Medical City, started construction. Some pig vaccines will be first commercialized in the China Medical City after the manufacturing base is completed in 2016. Intervet Holding BV and CAHIC signed a cooperation agreement in 2015, planning to jointly explore domestic and foreign markets and enhance competitiveness.

However, Chinese local animal vaccine companies are also scaling up efforts for research and development, making their presence in high-end vaccines and expanding varieties of vaccines. There were 25 kinds of registered animal vaccines in China in 2015, a year-on-year growth of 78.6%, including 10 kinds of pig vaccines, 10 kinds of poultry vaccines, and 5 kinds of other animal vaccines like Mink Hemorrhagic Pneumonia Bivalent Vaccine, Inactivated (Serotype G, Stain WD005 + Serotype B, Stain DL007) and Turbot EdwardsiellatardaVaccine, Live (Strain EIBAV1).

Moreover, great progress has been made in pet vaccines. Rabies vaccines, inactivated produced by Pulike Biological Engineering, Tianjin Ringpu Bio-technology, and Shanghai Hile Bio-Technology are expected to be approved and go on the market at the end of 2016 or in 2017.

image1

China Animal Vaccine Industry Report, 2016-2020 by ResearchInChina highlights the followings:

  • Global animal vaccine industry (market size/structure, competitive landscape, etc.);
  • China's animal vaccine industry (market size/structure, competitive landscape, import/export, etc.);
  • China's animal vaccine industry (policy environment, social environment, downstream demand, etc.);
  • Market segments (pig vaccines, poultry vaccines) in China (market size, competitive landscape, etc.);
  • 16 Chinese animal vaccine producers (operation, animal vaccine business, forecast & outlook, etc.);
  • Chinese animal vaccine market and market segments (market size/structure forecast) during 2016-2020.

Table of Contents

1. Overview of Animal Vaccine

  • 1.1 Definition
  • 1.2 Classification
  • 1.3 Industry Chain

2. Status Quo of Animal Vaccine Industry

  • 2.1 Global Market
    • 2.1.1 Market Size
    • 2.1.2 Market Structure
    • 2.1.3 Competitive Landscape
  • 2.2 Chinese Market
    • 2.2.1 Market Size
    • 2.2.2 Market Structure
    • 2.2.3 Import and Export
    • 2.2.4 Profit
    • 2.2.5 Entry Barriers
    • 2.2.6 Competitive Landscape
    • 2.2.7 Trends

3. Development Environment for China Animal Vaccine Industry

  • 3.1 Policy Environment
    • 3.1.1 Major Policies
    • 3.1.2 Tendering System for Compulsory Immunization Vaccine
  • 3.2 Social Environment
    • 3.2.1 Stable Development of Farming Industry
    • 3.2.2 Large-scale Farming Becomes a Trend
    • 3.2.3 Frequent Outbreaks of Animal Epidemics

4. Chinese Animal Vaccine Industry Segments

  • 4.1 Governmental Mandatory Vaccine
    • 4.1.1 FMD Vaccine
    • 4.1.2 Bird Flu Vaccine
    • 4.1.3 PRRS Vaccine
    • 4.1.4 Swine Fever Vaccine
  • 4.2 Market-oriented Vaccine
    • 4.2.1 PCV Vaccine
    • 4.2.2 Newcastle Disease Vaccine
  • 4.3 Pet Vaccine

5 Key Enterprises

  • 5.1 CAHIC
    • 5.1.1 Profile
    • 5.1.2 Operation
    • 5.1.3 Revenue Structure
    • 5.1.4 Gross Margin
    • 5.1.5 R&D
    • 5.1.6 Animal Vaccine Business
    • 5.1.7 Forecast and Outlook
  • 5.2 Jinyu Bio-technology
    • 5.2.1 Profile
    • 5.2.2 Operation
    • 5.2.3 Revenue Structure
    • 5.2.4 Gross Margin
    • 5.2.5 R&D
    • 5.2.6 Animal Vaccine Business
    • 5.2.7 Forecast and Outlook
  • 5.3 Tecon
    • 5.3.1 Profile
    • 5.3.2 Operation
    • 5.3.3 Revenue Structure
    • 5.3.4 Gross Margin
    • 5.3.5 R&D
    • 5.3.6 Clients and Suppliers
    • 5.3.7 Animal Vaccine Business
    • 5.3.8 Forecast and Outlook
  • 5.4 Tech-bank
    • 5.4.1 Profile
    • 5.4.2 Operation
    • 5.4.3 Revenue Structure
    • 5.4.4 Gross Margin
    • 5.4.5 R&D
    • 5.4.6 Animal Vaccine Business
    • 5.4.7 Forecast and Outlook
  • 5.5 ShenghuaBiok
    • 5.5.1 Profile
    • 5.5.2 Operation
    • 5.5.3 Revenue Structure
    • 5.5.4 Gross Margin
    • 5.5.5 R&D
    • 5.5.6 Animal Vaccine Business
    • 5.5.7 Forecast and Outlook
  • 5.6 Ringpu Bio-technology
    • 5.6.1 Profile
    • 5.6.2 Operation
    • 5.6.3 Revenue Structure
    • 5.6.4 Gross Margin
    • 5.6.5 R&D
    • 5.6.6 Animal Vaccine Business
    • 5.6.7 Forecast and Outlook
  • 5.7 Wens Dahuanong
    • 5.7.1 Profile
    • 5.7.2 Operation
    • 5.7.3 Revenue Structure
    • 5.7.4 Gross Margin
    • 5.7.5 R&D
    • 5.7.6 Animal Vaccine Business
    • 5.7.7 Forecast and Outlook
  • 5.8 Hile Bio
    • 5.8.1 Profile
    • 5.8.2 Operation
    • 5.8.3 Revenue Structure
    • 5.8.4 Gross Margin
    • 5.8.5 R&D
    • 5.8.6 Animal Vaccine Business
    • 5.8.7 Forecast and Outlook
  • 5.9 Pulike
    • 5.9.1 Profile
    • 5.9.2 Operation
    • 5.9.3 Revenue Structure
    • 5.9.4 Gross Margin
    • 5.9.5 R&D
    • 5.9.6 Animal Vaccine Business
    • 5.9.7 Forecast and Outlook
  • 5.10 Chopper
    • 5.10.1 Profile
    • 5.10.2 Operation
    • 5.10.3 Revenue Structure
    • 5.10.4 Gross Margin
    • 5.10.5 R&D
    • 5.10.6 Clients and Suppliers
    • 5.10.7 Animal Vaccine Business
  • 5.11 Other Enterprises
    • 5.11.1 Yikang Biological
    • 5.11.2 Weike Biotechnology
    • 5.11.3 Guangdong Winsun Bio-pharmaceutical
    • 5.11.4 Shenlian Biotechnology
    • 5.11.5 Keqian Biology
    • 5.11.6 Nannong Hi-Tech

6. Summary and Forecast

  • 6.1 Summary
  • 6.2 Development Forecast
    • 6.2.1 Swine Vaccine
    • 6.2.2 Poultry Vaccine
    • 6.2.3 Cattle and Sheep Vaccine
    • 6.2.4 Pet Vaccine

Selected Charts

  • Classification of Animal Health Products
  • Animal Vaccine Types (by Constituent and Feature) and Characteristics
  • Animal Vaccine Industry Chain
  • Classification of Animal Epidemics in China
  • Global Animal Vaccine Market Size, 2008-2020E
  • Global Animal Vaccine Consumption Structure, 2015
  • Major M&A Events in Global Animal Health Industry, 2005-2015
  • Profile of Global Animal Health Products Giants
  • Development Process of Chinese Compulsory Vaccination Policies
  • Chinese Animal Vaccine Market Size, 2004-2015
  • China's Animal Vaccine Net Import Value and Dependence on Export, 2008-2015
  • China's Animal Vaccine Product Structure (by Animal Species), 2010-2015
  • Newly-approved Pig/Poultry Vaccines in China, 2015
  • China's Animal Vaccine Import and Export Volume, 2009-2015
  • China's Average Animal Vaccine Import and Export Prices, 2009-2015
  • China's Animal Vaccine Import Sources (by Import Value), 2015
  • China's Animal Vaccine Export Destinations (by Export Value), 2015
  • Main Regions Which Import Animal Vaccines and Their Share in Import Volume in China, 2015
  • Main Regions Which Export Animal Vaccines and Their Share in Export Volume in China, 2015
  • Gross Margin of Animal Vaccine Business of Major Listed Animal Vaccine Companies in China, 2011-2015
  • Barriers to Entry into Animal Vaccine Industry in China
  • Major Chinese Animal Vaccine Manufacturers, 2015
  • Competitive Landscape of China Animal Vaccine Industry, 2015
  • Proportion of Large-scale Pig Breeding in China, 2006-2015
  • Vaccines' Percentage of Total Costs in Different Breeding Sizes
  • Epidemic Prevention Expenses for Live Pigs Bred on a Large Scale and YoY in China, 2005-2013
  • Gap between Chinese Vaccine Production Process and International Advanced Level
  • Sino-foreign Joint Animal Vaccine Enterprises, 1990-2015
  • Major Polices on China Animal Vaccine Industry, 2010-2015
  • Compulsory Immunization Plan of Animal Epidemics in China, 2016
  • Animal Diseases worth Priority Prevention in China, 2012-2020
  • Defects of China's Compulsory Immunization Tender System
  • Direction for China's Compulsory Immunization Tender System Reform
  • Output of Meat, Eggs and Milk in China, 2009-2015
  • China's Meat Product Structure (by Output), 2011-2015
  • Farming Scale Degree in China, 2010-2020E
  • Overview of Common Animal Epidemics in China
  • China's Animal Vaccine Market Structure (by Sales Method)
  • Usage of Vaccines by Small and Medium-sized Live Pig Farmers by Product in China (%)
  • Winning Prices of Main Animal Vaccines in China, 2015
  • Competitive Landscape of Main Compulsory Immunization Vaccine Markets in China, 2015
  • Market Structure of Animal Vaccines Subject to National Compulsory Immunization Programme, 2015
  • Potential Scale of Chinese Foot-and-Mouth Disease Vaccine Market
  • Performance Comparison between Swine Fever Vaccines in China
  • Classification and Market Conditions of Market-oriented Vaccines in China
  • Market Capacity of Some Non-compulsory Vaccines in China, 2015
  • Market Prices of PCV Vaccines in China by Enterprise, 2015
  • Pet Vaccine Suppliers in Chinese Market and Their Products
  • R&D of Main Pet Vaccines in China by the end of Apr 2016
  • CAHIC's Revenue and Net Income, 2009-2016
  • CAHIC's Output, Sales Volume and Inventory, 2015 (10k ml/10k doses, ton)
  • CAHIC's Revenue (by Product), 2011-2015
  • CAHIC's Revenue Structure (by Product), 2011-2014
  • CAHIC's Revenue (by Region), 2011-2015
  • CAHIC's Revenue Structure (by Region), 2011-2015
  • Gross Margin of CAHIC's Main Products, 2011-2015
  • CAHIC's R & D Costs and % of Total Revenue, 2011-2015
  • CAHIC's Animal Vaccine Subsidiaries and Their Products
  • Revenue from and Gross Margin of Veterinary Vaccines of CAHIC, 2011-2015
  • CAHIC's Varieties/Output/Sales Volume of and Revenue/Net Income from Main Veterinary Vaccines, 2015
  • Winning Prices of CAHIC's Veterinary Vaccines, 2015
  • CAHIC's Revenue and Net Income, 2015-2020E
  • Jinyu Bio-technology's Revenue and Net Income, 2009-2016
  • Jinyu Bio-technology's Revenue (by Product), 2011-2015 (Unit: RMB mln)
  • Jinyu Bio-technology's Revenue Structure (by Product), 2011-2015
  • Jinyu Bio-technology's Revenue (by Region), 2011-2015
  • Jinyu Bio-technology's Revenue Structure (by Region), 2011-2015
  • Gross Margin of Jinyu Bio-technology's Main Business, 2010-2015
  • Jinyu Bio-technology's R&D Costs and % of Total Revenue, 2011-2015
  • Animal Vaccine Subsidiaries of Jinyu Bio-technology, 2015
  • Jinyu Bio-technology's Output/Sales Volume/Inventory of Main Vaccines, 2015
  • Jinyu Bio-technology's Revenue from and Gross Margin of Vaccines, 2011-2015
  • Main Reserve Vaccines of Jinyu Bio-technology
  • Revenue and Net Income of JinyuBaoling, 2012-2015
  • Assets and Net Income of Yangzhou Uni-Bio Pharmaceutical, 2012-2015
  • Jinyu Bio-technology's Revenue and Net Income, 2015-2020E
  • Tecon's Revenue and Net Income, 2009-2016
  • Tecon's Revenue (by Product), 2011-2015
  • Tecon's Revenue Structure (by Product), 2011-2015
  • Tecon's Revenue (by Region), 2011-2015
  • Tecon's Revenue Structure (by Region), 2011-2015
  • Gross Margin of Tecon's Main Products, 2011-2015
  • Tecon's R & D Costs and % of Total Revenue, 2011-2015
  • Tecon's Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
  • Name List and Revenue Contribution of Tecon's Top 5 Clients, 2015
  • Tecon's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2015
  • Name List and Procurement Contribution of Tecon's Top 5 Suppliers, 2015
  • Tecon's Animal Vaccine Production Bases and Capacity, 2015
  • Animal Vaccines under Research and Progress of Tecon by the end of Apr 2016
  • Revenue and Gross Margin of Tecon, 2011-2015
  • Tecon's Revenue and Net Income, 2015-2020E
  • Tech-bank's Revenue and Net Income, 2009-2015
  • Tech-bank's Revenue (by Product), 2011-2015
  • Tech-bank's Revenue (by Region), 2011-2015
  • Tech-bank's Revenue Structure (by Region), 2011-2015
  • Tech-bank's Gross Margin of Main Products, 2011-2015
  • Tech-bank's R&D Costs and % of Total Revenue, 2011-2015
  • Revenue and Net Income of Chengdu Tech-bank, 2010-2015
  • Tech-bank's Revenue and Net Income, 2015-2020E
  • ShenghuaBiok's Revenue and Net Income, 2009-2015
  • ShenghuaBiok's Revenue (by Product), 2011-2015
  • ShenghuaBiok's Revenue Structure (by Product), 2011-2015
  • ShenghuaBiok's Revenue (by Region), 2011-2013
  • ShenghuaBiok's Revenue Structure (by Region), 2011-2015
  • Gross Margin of ShenghuaBiok's Main Products, 2011-2015
  • Shenghua's R&D Costs and % of Total Revenue, 2011-2015
  • Revenue and Net Income of Qingdao Yebio, 2009-2015
  • ShenghuaBiok's Revenue and Net Income, 2015-2020E
  • Ringpu Bio-technology's Revenue and Net Income, 2009-2016
  • Ringpu Bio-technology's Revenue (by Product), 2011-2015
  • Ringpu Bio-technology's Revenue Structure (by Product), 2011-2015
  • Ringpu Bio-technology's Revenue (by Region), 2012-2015
  • Ringpu Bio-technology's Revenue Structure (by Region), 2012-2013
  • Ringpu Bio-technology's Gross Margin of Main Products, 2011-2015
  • Ringpu Bio-technology's R&D Costs and % of Total Revenue, 2011-2015
  • Varieties of Animal Vaccines Launched of Ringpu Bio-technology, 2014-Jan 2016
  • Ringpu Bio-technology's Animal Vaccine Output and Sales Volume (by Product), 2011-2015
  • Sales and Gross Margin of Ringpu Bio-technology's Animal Vaccines (by Product), 2013-2015
  • Ringpu Bio-technology's Animal Vaccine Subsidiaries and Their Products, 2015
  • Revenue and Net Income of Ringpu Bio-technology's Animal Vaccine Subsidiaries, 2013-2015
  • Ringpu Bio-technology's Revenue and Net Income, 2015-2020E
  • Wens Dahuanong's Revenue and Net Income, 2009-2015
  • Output and Sales Volume of Wens Dahuanong's Main Products, 2013-2014
  • Wens Dahuanong's Revenue (by Product), 2011-2015
  • Wens Dahuanong's Revenue Structure (by Product), 2011-2015
  • Wens Dahuanong's Revenue (by Region), 2011-2014
  • Wens Dahuanong's Revenue Structure (by Region), 2011-2014
  • Gross Margin of Wens Dahuanong's Main Products, 2011-2015
  • Wens Dahuanong's R&D Expenditure and % of Total Revenue, 2011-2015
  • Revenue and Gross Margin of Wens Dahuanong's Animal Vaccine Products , 2011-2015
  • Output, Sales Volume and Sales-output Ratio of Wens Dahuanong's Veterinary Biologics, 2012-2014
  • Wens Dahuanong's Revenue and Net Income, 2015-2020E
  • Hile Bio's Main Products
  • Hile Bio's Revenue and Net Income, 2011-2016
  • Hile Bio's Revenue Structure (by Product), 2011-2015
  • Hile Bio's Revenue Structure (by Product), 2011-2015
  • Hile Bio's Revenue (by Region), 2011-2015
  • Hile Bio's Revenue Structure (by Region), 2011-2015
  • Gross Margin of Hile Bio's Main Products, 2011-2015
  • Hile Bio's R&D Costs and % of Total Revenue, 2011-2015
  • Hile Bio's Animal Vaccines under Research and R&D Investment, 2015
  • Hile Bio's Revenue Structure (by Sales Method), 2011-2015
  • Hile Bio's Swine Vaccine Output, Sales Volume and Inventory, 2015
  • Selling Prices of Hile Bio's Main Products, 2011-2013
  • Hile Bio's Revenue and Net Income, 2015-2020E
  • Key Holding and Joint-stock Subsidiaries of Pulike, 2015
  • Pulike's Revenue and Net Income, 2012-2016
  • Pulike's Sales Model and Revenue Structure, 2014-2015
  • Pulike's Revenue (by Product), 2012-2015
  • Pulike's Revenue Structure (by Product), 2012-2015
  • Gross Margin of Pulike's Main Products, 2012-2015
  • Pulike's R&D Costs and % of Total Revenue, 2011-2015
  • Output, Sales Volume, and Inventory of Pulike's Animal Vaccines, 2015
  • Output and Sales Volume of Pulike's Main Animal Vaccines, 2015
  • Revenue and Gross Margin of Pulike, 2012-2015
  • Pulike's Revenue and Net Income, 2015-2020
  • Chopper's Revenue and Net Income, 2009-2013
  • Chopper's Revenue (by Product), 2011-2013
  • Chopper's Revenue Structure (by Product), 2011-2013
  • Chopper's Revenue (by Region), 2011-2013
  • Chopper's Revenue Structure (by Region), 2011-2013
  • Sales of Chopper's Main Vaccine Products, 2011-2013
  • Chopper's R & D Costs and % of Total Revenue, 2011-2013
  • Chopper's Revenue from Top 5 Clients and % of Total Revenue, 2011-2013
  • Chopper's Procurement from Top 5 Suppliers and % of Total Procurement, 2011-2013
  • Name List and Procurement Contribution of Chopper's Suppliers, 2013
  • Chopper's Products and Clients (by Sales Method)
  • Chopper's Sales Structure by Sales Method, 2011-2013
  • Sales of Chopper's Main Vaccine Products, 2011-2013 (Unit: RMB mln)
  • Chopper's Sales Structure by Main Vaccine Product, 2011-2013
  • Chopper's Vaccine Capacity, Output and Capacity Utilization, 2011-2013
  • Chopper's Vaccine Output, Sales Volume and Sales-output Ratio, 2011-2013
  • Average Selling Price of Chopper's Main Vaccine Products, 2011-2013
  • Chopper's Investment Plan, 2014
  • Yikang's Revenue and Net Income, 2009-2011
  • Yikang's Revenue (by Product), 2009-2011
  • Yikang's Revenue (by Region), 2009-2011
  • Gross Margin of Yikang's Main Products, 2009-2011
  • Yikang's Animal Vaccine Production Lines, 2009-2011
  • Yikang's Capacity, Output and Capacity Utilization, 2009-2011
  • Yikang's Output, Sales Volume and Sales-output Ratio, 2009-2011
  • Average Selling Price of Yikang's Main Products, 2009-2011
  • Yikang's Revenue Structure (by Sales Method), 2009-2011
  • Animal Vaccine Revenue of Major Animal Vaccine Companies in China, 2011-2015
  • Chinese Animal Vaccine Market Size, 2014-2020E
  • Chinese Animal Vaccine Market Structure (by Animal Attributes), 2013 vs 2016E
  • Chinese Swine Vaccine Market Size, 2015-2020E
  • Chinese Poultry Vaccine Market Size, 2015-2020E
  • Chinese Cattle and Sheep Vaccine Market Size, 2015-2020E
  • Chinese Pet Vaccine Market Size, 2015-2020E

Related Companies

  • China Animal Husbandry Industry Co.,Ltd.(600195.SH)
  • INNER MONGOLIA JINYU GROUP CO.,LTD(600201.SH)
  • Xinjiang Tecon Animal Husbandry Bio-Technologu Co.,Ltd.(002100.SZ)
  • Ningbo Tech-bank Co.,Ltd.(002124.SZ)
  • Zhejiang Shenghua Biok Biology Co.,Ltd.(600226.SH)
  • Tianjin Ringpu Bio-technology Co.,Ltd.(300119.SZ)
  • Guangdong DaHuaNong Animal Health Products Co.,Ltd.(300186.SZ)
Back to Top